Journal
SEMINARS IN CANCER BIOLOGY
Volume 59, Issue -, Pages 80-91Publisher
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.semcancer.2019.06.002
Keywords
Akt; Mutation; Cancer hallmarks; miRNA; lncRNA; Akt inhibitor
Categories
Funding
- UGC-SAP grant from Government of India, New Delhi
- DST-FIST grant from Government of India, New Delhi
- DAE-BRNS, India
- DHR-MRU, India
- DBT, India
- ICMR, India
Ask authors/readers for more resources
Akt is a serine/threonine kinase and it participates in the key role of the PI3K signaling pathway. The Akt can be activated by a wide range of growth signals and the biochemical mechanisms leading to Akt activation are well defined. Once activated, Akt modulates the function of many downstream proteins involved in cellular survival, proliferation, migration, metabolism, and angiogenesis. The Akt is a central node of many signaling pathways and it is frequently deregulated in many types of human cancers. In this review, we provide an overview of Akt function and its role in the hallmarks of human cancer. We also discussed various mechanisms of Akt dysregulation in cancers, including epigenetic modifications like methylation, post-transcriptional non-coding RNAs-mediated regulation, and the overexpression and mutation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available